Comorbidities in Chronic Kidney Disease: From Diagnosis to Management ( Renal and Urologic Disorders )

Publication series :Renal and Urologic Disorders

Author: Luca Di Lullo  

Publisher: Nova Science Publishers, Inc.‎

Publication year: 2016

E-ISBN: 9781634850872

P-ISBN(Paperback): 9781634850704

Subject: R69 urological (genito - urinary diseases)

Keyword: 泌尿科学(泌尿生殖系疾病),外科学

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Comorbidities in Chronic Kidney Disease: From Diagnosis to Management

Chapter

Increased in Small, Dense LDL Particles

THE EFFECT OF DIALYSIS

DYSLIPIDEMIA AND CV OUTCOME IN CKD

Total Cholesterol

IDL Cholesterol

Lp(a) Concentrations and Apo(a) Polymorphism

Apolipoproteins

LIPID MANAGEMENT IN CKD

Effect of Statins in Primary Prevention of CVD in ESRD Patients

Non-Statins Lipid Lowering Agents

Nicotinic Acid

Fibrates

Ezetimibe

Fish Oil

Bile Acid Resins

PCSK9 Inhibitors

Others Therapies

REFERENCES

Chapter 4 CHRONIC KIDNEY DISEASE – MINERAL BONE DISEASE (CKD-MBD): PRESENT AND FUTURE PERSPECTIVES

ABSTRACT

INTRODUCTION

CALCIUM, PHOSPHATE, PTH AND VITAMIN D HOMEOSTASIS IN NORMAL RENAL FUNCTION CONDITION

BONE MINERAL ABNORMALITIES IN CHRONIC KIDNEY DISEASE: THE PHOSPHOROCENTRIC PARADIGM

CLINICAL CONSEQUENCES OF CKD-MBD

TREATMENT STRATEGIES IN CKD-MBD

DIALYSIS

NUTRITIONAL THERAPY

PHOSPHATE BINDERS

VITAMIN D

CALCIMIMETICS

UNMET MEDICAL NEED AND FUTURE PERSPECTIVES

CONCLUSION

REFERENCES

Chapter 5 ANEMIA MANAGEMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE

ABSTRACT

INTRODUCTION

DIAGNOSIS AND EVALUATION OF ANEMIA IN CKD

USE OF IRON TO TREAT ANEMIA IN CKD

USE OF ERYTHROPOIETIC-STIMULATING AGENTS TO TREAT ANEMIA IN CKD

RED CELL TRANSFUSION TO TREAT ANEMIA IN CKD

CONCLUSION

REFERENCES

Chapter 6 CORONARY ARTERY DISEASE AND CHRONIC KIDNEY DISEASE

ABSTRACT

EPIDEMIOLOGY

PATHOPHYSIOLOGY

DIAGNOSIS

PROGNOSIS

PHARMACOLOGIC MANAGEMENT

CORONARY REVASCULARIZATION

REFERENCES

Chapter 7 ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN CHRONIC KIDNEY DISEASE

ABSTRACT

INTRODUCTION

EPIDEMIOLOGY

Incidence of Cardiac Sudden Death in General Population

Incidence of SCD in CKD Patients

RISK FACTORS AND HYPOTHESIZED MECHANISMS OF SCD IN CKD

THERAPEUTIC STRATEGIES TO PREVENT SCD

Pharmacological Drugs

Non-Pharmacological Options

CONCLUSION

REFERENCES

Chapter 8 CARDIORENAL SYNDROME

ABSTRACT

INTRODUCTION

1. TYPE – 1 CARDIO – RENAL SYNDROME

1.1. Pathophysiology

1.2. Diagnosis

1.3. Outcomes and Treatment

2. TYPE – 2 CARDIO – RENAL SYNDROME

2.1. Pathophysiology

2.2. Diagnosis

2.3. Outcomes and Treatment

3. TYPE – 3 CARDIORENAL SYNDROME

3.1. Pathophysiology

3.2. Diagnosis

3.3. Outcomes and Treatment

4. TYPE – 4 CARDIO RENAL SYNDROME

4.1. Pathophysiology

4.2. Diagnosis

4.3. Outcomes and Treatment

5. TYPE – 5 CARDIO RENAL SYNDROME

5.1. Pathophysiology

5.2. Diagnosis

5.3. Outcomes and Treatment

REFERENCES

Chapter 9 THE HEPATO – RENAL SYNDROME

ABSTRACT

BACKGROUND

HEPATO – RENAL SYNDROME: DEFINITION

PATHOGENESIS OF HEPATO – RENAL SYNDROME

DIAGNOSIS AND BIOMARKERS OF HRS

MANAGEMENT STRATEGIES

a) Pharmacological Approach

b) Non – Pharmacological Approach

REFERENCES

Chapter 10 CONTRAST-INDUCED ACUTE KIDNEY INJURY

ABSTRACT

INTRODUCTION

EPIDEMIOLOGY

RISK FACTORS

PATHOGENESIS

CLINICAL DESCRIPTION

PREVENTION STRATEGIES

REFERENCES

ABOUT THE EDITOR

INDEX

The users who browse this book also browse


No browse record.